Inventor profile of:

Glenn E. Dale

City:

Basel

Country:

Switzerland

Published Applications:

23

Last publication date:

2026-04-09

Top Assignees for applications by Glenn E. Dale

The entities that hold a legal rights for patent applications filed by inventor Dale Glenn E.:

Recent patent applications by Dale Glenn E.

Glenn E. Dale from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-09
US20260098046A1
Chemistry; metallurgy

RIFABUTIN ANALOGS FOR THE TREATMENT OF DISEASE

#2 | 2025-12-11
US20250376472A1
Chemistry; metallurgy

3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES

#3 | 2025-11-27
US20250360115A1
Human necessities

RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS

#4 | 2025-11-27
US20250360114A1
Human necessities

INTRAVENOUS RIFABUTIN FORMULATION AND METHODS OF MAKING

#5 | 2025-09-11
US20250281469A1
Human necessities

RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS

#6 | 2025-07-24
US20250235434A1
Human necessities

RIFABUTIN ANALOGS FOR THE TREATMENT OF DISEASE

#7 | 2025-07-03
US20250213575A1
Human necessities

8-HETEROCYCLIC-3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES AS ANTI-BACTERIALS

#8 | 2025-03-27
US20250101039A1
Chemistry; metallurgy

RIFAMYCIN DERIVATIVES FOR THE TREATMENT OF DISEASES

#9 | 2025-02-13
US20250051356A1
Chemistry; metallurgy

RIFABUTIN ANALOGS FOR THE TREATMENT OF DISEASE

#10 | 2024-06-20
US20240197697A1
Human necessities

RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS

#11 | 2024-02-08
US20240041845A1
Human necessities

Rifabutin treatment methods, uses, and compositions

#12 | 2024-01-04
US20240000759A1
Human necessities

ANTIBIOTIC COMBINATION THERAPIES

#13 | 2023-11-16
US20230364065A1
Human necessities

ANTIBIOTIC COMBINATION THERAPIES

#14 | 2023-05-04
US20230132691A1
Human necessities

Rifabutin treatment methods, uses, and compositions

#15 | 2023-03-02
US20230066182A1
Human necessities

Rifabutin treatment methods, uses, and compositions

#16 | 2022-06-16
US20220184048A1
Human necessities

Antibiotic combination therapies

#17 | 2021-09-16
US20210284693A1
Chemistry; metallurgy

Beta-hairpin peptidomimetics

#18 | 2021-03-18
US20210077472A1
Human necessities

Antibiotic combination therapies

#19 | 2021-03-18
US20210077471A1
Human necessities

Rifabutin treatment methods, uses, and compositions

#20 | 2021-03-18
US20210077470A1
Human necessities

Rifabutin treatment methods, uses, and compositions

#21 | 2015-08-13
US20150224168A1
Human necessities

Combinations with a backbone-cyclized peptide

#22 | 2015-08-06
US20150216927A1
Human necessities

Combinations with a backbone-cyclized peptide

#23 | 2006-03-02
US20060046978A1
Chemistry; metallurgy

Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE)

InventorID:

1245672 ⎘